{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:59:01Z","timestamp":1793627941652,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09555"],"award-info":[{"award-number":["18K09555"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjoms.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bjoms.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T16:27:33Z","timestamp":1635179253000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series"],"prefix":"10.1016","volume":"60","author":[{"given":"Daigo","family":"Yoshiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Habu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Sasaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjoms.2021.10.004_b0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2021.10.004_b0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2021.10.004_b0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2021.10.004_b0020","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s11999-011-1863-5","article-title":"Defining ethnic and racial differences in osteoporosis and fragility fractures","volume":"469","author":"Cauley","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bjoms.2021.10.004_b0030","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1\u201334) (teriparatide) improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0749-0690(02)00074-5","article-title":"The anabolic effects of parathyroid hormone therapy","volume":"19","author":"Rubin","year":"2003","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.bjoms.2021.10.004_b0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1\u201334)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2021.10.004_b0045","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00198-013-2277-x","article-title":"Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws","volume":"24","author":"Yoshiga","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bjoms.2021.10.004_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijscr.2016.02.028","article-title":"Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: a case report","volume":"21","author":"Yao","year":"2016","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.bjoms.2021.10.004_b0055","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1007\/s00784-019-02830-2","article-title":"Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw","volume":"23","author":"Zandi","year":"2019","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.bjoms.2021.10.004_b0060","doi-asserted-by":"crossref","first-page":"20130144","DOI":"10.1259\/dmfr.20130144","article-title":"Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model","volume":"43","author":"Ersan","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.bjoms.2021.10.004_b0065","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2002-221061","article-title":"New bone formation with teriparatide human parathyroid hormone-(1\u201334) is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats","volume":"144","author":"Ma","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bjoms.2021.10.004_b0070","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjoms.2021.10.004_b0075","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bjoms.2021.10.004_b0080","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jbmr.3051","article-title":"Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis","volume":"32","author":"Cosman","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2013.11.011","article-title":"Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment","volume":"59","author":"Ma","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bjoms.2021.10.004_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2019.01.006","article-title":"Weekly teriparatide treatment increases vertebral body strength by improving cortical shell architecture in ovariectomized cynomolgus monkeys","volume":"121","author":"Fujihara","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bjoms.2021.10.004_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00223-018-0500-7","article-title":"Once-weekly teriparatide treatment prevents microdamage accumulation in the lumbar vertebral trabecular bone of ovariectomized cynomolgus monkeys","volume":"104","author":"Yoshitake","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bjoms.2021.10.004_b0115","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjoms.2021.10.004_b0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jbmr.1765","article-title":"PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis","volume":"28","author":"Dhillon","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bjoms.2021.10.004_b0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tripleo.2008.09.019","article-title":"Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw","volume":"107","author":"Wilde","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bjoms.2021.10.004_b0130","doi-asserted-by":"crossref","first-page":"e67906","DOI":"10.1371\/journal.pone.0067906","article-title":"Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages","volume":"8","author":"Muratsu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bjoms.2021.10.004_b0135","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijom.2013.06.011","article-title":"Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats","volume":"42","author":"Tsurushima","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2021.10.004_b0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41232-018-0074-9","article-title":"Zoledronic acid exacerbates inflammation through M1 macrophage polarization","volume":"38","author":"Kaneko","year":"2018","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.bjoms.2021.10.004_b0145","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.4317\/jced.51213","article-title":"Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - prognostic factors in the treatment of BRONJ","volume":"6","author":"Yoshiga","year":"2014","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.bjoms.2021.10.004_b0150","doi-asserted-by":"crossref","first-page":"101072","DOI":"10.1016\/j.bonr.2021.101072","article-title":"The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: a 12-year retrospective study of 129 patients","volume":"14","author":"Kaibuchi","year":"2021","journal-title":"Bone Rep"}],"container-title":["British Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435621003557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435621003557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:29:57Z","timestamp":1759418997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0266435621003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0266435621003557"],"URL":"https:\/\/doi.org\/10.1016\/j.bjoms.2021.10.004","relation":{},"ISSN":["0266-4356"],"issn-type":[{"value":"0266-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series","name":"articletitle","label":"Article Title"},{"value":"British Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjoms.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}